Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28423220 | 0.96 | CYP1A2 (0.38) | CYP1A2LMNAALDH1A1L3MBTL1 | |
| SCHEMBL1389781 | 0.81 | LMNA (0.41) | SMN1; SMN2LMNA | |
| SCHEMBL2250599 | 0.80 | KMT2A (0.34) | CYP1A2SMN1; SMN2LMNAMEN1ALDH1A1 | |
| SCHEMBL25266723 | 0.79 | NPC1 (0.37) | CYP1A2SMN1; SMN2LMNAMEN1ALDH1A1 | |
| SCHEMBL31538680 | 0.79 | LMNA (0.39) | CYP1A2SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL28843680 | 0.79 | LMNA (0.39) | CYP1A2SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL21767983 | 0.79 | KDM4E (0.35) | CYP1A2SMN1; SMN2LMNAMEN1ALDH1A1 | |
| SCHEMBL28413030 | 0.77 | TYMP (0.36) | CYP1A2SMN1; SMN2LMNAALDH1A1HPGD | |
| SCHEMBL25292012 | 0.76 | CYP1A2 (0.35) | CYP1A2SMN1; SMN2LMNAMEN1ALDH1A1 | |
| SCHEMBL6172765 | 0.76 | ALDH1A1 (0.34) | CYP1A2SMN1; SMN2MEN1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3670507-B1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-05-06 | — | — | EP | claimed |
| US-20240018127-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-18 | — | — | US | claimed |
| CN-116568680-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2023-08-08 | — | — | CN | claimed |
| EP-4185582-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | Samsung Display Co., Ltd. (KR) | 2023-05-31 | — | — | EP | claimed |
| EP-3837255-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2022-10-26 | — | — | EP | claimed |
| EP-3483156-B1 | ORGANIC MOLECUES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-09-16 | — | — | EP | claimed |
| US-12598909-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-04-07 | — | — | US | disclosed |
| US-12563962-B2 | Organic light-emitting device and electronic apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-02-24 | — | — | US | disclosed |
| US-12550606-B2 | Organic light-emitting device and electronic apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-02-10 | — | — | US | disclosed |
| US-12490652-B2 | Organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2025-12-02 | — | — | US | disclosed |
| EP-3809478-B1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2025-09-17 | — | — | EP | disclosed |
| US-12384766-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-08-12 | — | — | US | disclosed |
| US-20250176423-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-05-29 | — | — | US | disclosed |
| EP-0078008-A2 | Reactive dyestuffs | BASF Aktiengesellschaft (DE) | 1983-05-04 | — | — | EP | disclosed |
| EP-0066714-A2 | Reactive dyestuffs | BASF Aktiengesellschaft (DE) | 1982-12-15 | — | — | EP | disclosed |
| US-4315859-A | STABILIZES PROVIDE PHOTSTABILITY OXIDATION RESISTANCE | CIBA-GEIGY CORPORATION (US) | 1982-02-16 | — | — | US | disclosed |
| EP-0042102-A1 | Process for preparing microcapsules | BAYER AG (DE) | 1981-12-23 | — | — | EP | disclosed |
| EP-0017768-B1 | REACTIVE DYESTUFFS AND THEIR USE | BASF Aktiengesellschaft (DE) | 1981-11-25 | — | — | EP | disclosed |
| EP-0031099-A2 | Compounds with reactive rests and their use in dyeing fibres | BASF Aktiengesellschaft (DE) | 1981-07-01 | — | — | EP | disclosed |
| EP-0013665-A1 | Polymeric polyamino 1,3,5-triazines containing at least one polyalkylpiperidine group, their preparation, their use in stabilizing an organic material and the material stabilized therewith | CIBA-GEIGY AG (CH) | 1980-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018127-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, ORC3, ORAI3 | CYP1A2 1598/4885SMN1; SMN2 4814/4885LMNA 3414/4885 |
| US-12563962-B2 | Organic light-emitting device and electronic apparatus including the same | EML4, TSNAX, TBL3 | CYP1A2 2055/4885SMN1; SMN2 842/4885LMNA 692/4885 |
| US-12598909-B2 | Heterocyclic compound and organic light-emitting device including the same | CRY1, HCN1, CLIC1 | CYP1A2 967/4885SMN1; SMN2 3787/4885LMNA 225/4885 |
| US-12384766-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNE2, CRY2 | CYP1A2 687/4885SMN1; SMN2 4280/4885LMNA 1505/4885 |
| US-12550606-B2 | Organic light-emitting device and electronic apparatus including the same | SCO2, SCN1B, CHRM1 | CYP1A2 584/4885SMN1; SMN2 4046/4885LMNA 864/4885 |
| US-20250176423-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CYP1A1, CYP1B1 | CYP1A2 9/4885SMN1; SMN2 3852/4885LMNA 3086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.